Breast cancer is the most common cancer in women and like every cancer, there is a chance of breast cancer recurrence even after completion of the prescribed treatment. Hence, every woman has to ...

Researchers have identified ways in which chemotherapy can damage healthy cells and found that some drugs can add decades of ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...

Cite this: Isolation of Rare Circulating Tumor Cells in Cancer Patients - Medscape - Jun 01, 2011. Abstract and Introduction Methodological Considerations for the Detection of CTCs ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with ...

(HealthDay News) — Circulating tumor DNA can be detected more than three years prior to a clinical cancer diagnosis, according to a research brief published online May 22 in Cancer Discovery ...

The Business Research Company's Lung Cancer Liquid Biopsy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% On All Global Market Reports With Code ONLINE30 – Stay ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial information to make decisions about treatment. But more studies are needed ...

Government data projects nearly 620,000 cancer deaths in the U.S. this year. However, a new "Trojan horse" therapy could ...